Literature DB >> 13915769

Aerosolized pancreatic dornase and antibiotics in pulmonary infections: use in patients with postoperative and nonoperative infections.

R SPIER, E WITEBSKY, J R PAINE.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS/therapy; DESOXYRIBONUCLEASE/therapy; LUNG ABSCESS/therapy; PNEUMONIA/therapy

Mesh：

Substances：

Year:  1961        PMID： 13915769     DOI： 10.1001/jama.1961.03040480008003

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  Reduction of Sputum Viscosity.

Authors: 
Journal:  Br Med J       Date:  1962-03-31

Review 2.  The role of recombinant human DNase in the treatment of patients with cystic fibrosis: many promises, more problems.

Authors:  M S Zach
Journal:  Thorax       Date:  1996-07       Impact factor: 9.139

3.  rhDNase in cystic fibrosis.

Authors:  S P Range; A J Knox
Journal:  Thorax       Date:  1995-04       Impact factor: 9.139

4.  Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.

Authors:  S Shak; D J Capon; R Hellmiss; S A Marsters; C L Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

5.  The mucolytic activity of amides: a new approach to mucus dispersion.

Authors:  D Waldron-Edward; S C Skoryna
Journal:  Can Med Assoc J       Date:  1966-06-11       Impact factor: 8.262

Review 6.  Dornase alfa. A review of its pharmacological properties and therapeutic potential in cystic fibrosis.

Authors:  H M Bryson; E M Sorkin
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

7.  Aerosol therapy in bronchopulmonary disease. A critical evaluation.

Authors:  A M OLSEN
Journal:  Calif Med       Date:  1962-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.